Decision
The committee finds the Conservative Analyst’s argument most compelling and decisive. The primary rationale is not just a 'pullba
ck’ but a fundamental valuation compression triggered by the combination of overbought exhaustion and a lack of near-term catalysts to justify the current premium. The $195 target is validated as a confluence of technical support ($193.03 April low) and a more reasonable P/S multiple (~10x). Final Decision: SELL Natera, Inc. (NTRA) at market. Protect capital and realize gains. Await a fundamental improvement in profitability alongside a significant price correction before reevaluating for a potential long position.